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Using Biological Monitoring to Assess Human
Exposure to Priority Toxicants
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Scientifically valid exposure assessment is crucial to risk assessment, risk management, and prevention of environmental disease. Scientists have
used three tools to assess exposure: exposure history/questionnaires, environmental monitoring (including personal monitoring), and biological mon-
itoring. Combinations of these tools usually provide the exposure information needed to meet objectives of human studies evaluating the exposure-
health effect relationship. Biological monitoring is a capable exposure assessment tool that has provided important information used in public health
decisions. We briefly describe how risk assessment and risk management decisions for lead, dioxin, and volatile organic compounds have substan-
tially benefited from exposure information obtained from biological monitoring. - Environ Health Perspect 1 03(Suppl 3):45-48 (1995)
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Introduction
Public health efforts to effectively prevent
disease from exposure to toxicants depend
on identification of toxicants to which
populations may be exposed, risk assess-
ment, and risk management. The weak
link in preventing environmental disease
for most toxicants or potential toxicants is
in risk assessment: specifically, exposure
assessment and dose-response assessment
for humans. We simply have limited infor-
mation on risk to human health from
environmental exposures to toxicants.
Traditionally, dose-response (expo-
sure-health effect) assessments are associ-
ated with animal studies. In these studies,
exposure assessment is relatively straight-
forward because animals are fed known
amounts of toxicant. Exposure assessment
is much more complex in epidemiologic
studies because human exposure does not
occur in such controlled conditions.
Focusing on improving exposure assess-
ment in human studies is worthwhile
because, although human studies are usu-
ally more difficult to conduct, they provide
valuable additional information to the risk
assessment process. Typically, human stud-
ies substantially decrease the uncertainties
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of human risk assessment. Human studies
can decrease uncertainties in risk assess-
ment much more if exposure assessment in
human studies is improved. For example,
in the case of lead, human studies that use
blood lead measurements to assess exposure
have provided the main science base for
both risk assessment and risk management
decisions (1-3).
Scientists have used three tools to
assess exposure in human studies: exposure
history/questionnaires (e.g., proximity to
exposure source, job title), environmental
monitoring (including personal monitor-
ing), and biological monitoring. Within
practical and monetary constraints, the
choice of exposure assessment tools is
determined by the specific objectives of
the epidemiologic study and the capabili-
ties of the exposure tools to meet those
objectives. Some exposure history/ques-
tionnaire data are almost always of value,
especially in assessing the effect of poten-
tial confounding factors (e.g., age, sex,
health status, smoking history).
Sometimes exposure history/question-
naire data plus environmental monitoring
adequately meet the study objectives, and
sometimes exposure history/questionnaire
data plus biological monitoring fill the
need. Some studies require data gained
from all three tools. In addition, the proper
choice of exposure assessment tools
continues to change as new and better
methods of environmental and biological
monitoring are developed.
In this article, we discuss, by way of
example, the importance of biological
monitoring in selected public health
decisions involving human exposure to
lead, dioxin, and volatile organic com-
pounds. A detailed discussion of the use of
biological monitoring is beyond the scope
of this presentation. Rather, the intent is to
present examples to show how biological
monitoring has already contributed to the
risk assessment and risk management
process.
Lead
In many ways, lead is the best example of
the potential of biological monitoring to
substantially improve human risk assess-
ment and risk management. Human health
studies generally use blood lead (or some-
times bone lead) measurements to assess
exposure. In the last 15 years, the accuracy,
precision, and cost of blood lead measure-
ments have improved greatly. Human
health studies on lead exposure have been
done across the world, and they provide a
large database for scientists assessing the
exposure-health effect relationship for lead
(1-3).
In evaluating dose-response relation-
ships in health studies of toxicant expo-
sures, many scientists use exposure
history/questionnaire-based indices to
divide the study participants into high-,
medium-, and low-exposure groups.
Unfortunately, the high-, medium-, and
low-exposure groups in one study cannot
be readily related to the high-, medium-, or
low-exposure groups in another study.
Consequently, scientists trying to examine
the combined data to evaluate an expo-
sure-health effects relationship cannot
credibly combine the results from multiple
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studies. Studies showing no health effect
are sometimes criticized as having minimal
exposures compared to those that showed
effects; but since there is no common basis
for exposure measurement, this cannot be
verified. In addition, the inability to validly
compare amounts of exposures in different
studies is a serious impediment to such
techniques as meta-analysis.
In human health studies of lead expo-
sure, blood lead measurements form the
basis for most lead exposure assessments
and thereby largely address this problem.
The amount of exposure as measured by
blood lead levels is directly comparable
between studies. A high blood lead group
of 30 to 45 pg/dl in one study is different
from a high blood lead group of 15 to 25
pg/dl in another study. This ability to
combine results from multiple studies has
been important in detecting the lowest-
observed-effect levels of lead exposure
among children. Such combined exposure-
health effect data from multiple studies of
children led CDC to recently lower its
threshold for action from a blood lead level
of 25 pg/dl (set in 1985) to 10 pg/dl (1).
A second example of the contribution
of blood lead measurements to risk assess-
ment and risk management is the U.S.
Environmental Protection Agency's (U.S.
EPA) action to remove lead from gasoline.
In 1982, the U.S. EPA proposed increasing
the amount of lead in gasoline, largely on
the basis of environmental measurements
that indicated that lead in gasoline con-
tributed little to human blood lead levels.
From 1976 through early 1980, the second
National Health and Nutrition Examina-
tion Survey (NHANES II) was conducted;
it included blood lead levels on over 9000
Americans. At the same time, due to the
introduction of unleaded gasoline, the
amount of lead used in gasoline was
declining in the United States.
The NHANES II blood lead levels
showed that as lead in gasoline in the
United States decreased about 55%, mean
blood lead levels paralleled the decline,
decreasing a total of about 6 pg/dl or 37%
(4). Environmental modeling did not accu-
rately predict the impact of gasoline lead on
blood lead because the contribution of lead
in dust to human exposure was not as well
characterized as it is today. The blood lead
measurements in NHANES II were a dom-
inant factor in the U.S. EPA's decision to
reverse its proposal to add lead to gasoline
and instead to propose (and implement) the
more rapid removal of lead from gasoline.
The NHANES III survey conducted
from 1988 through 1994 again includes
measurements of blood lead on a sample of
persons representing the U.S. noninstitu-
tionalized civilian population. Blood lead
measurements from NHANES III will
show the effect on blood lead levels of
removing almost all of the remaining lead
from gasoline. Surveillance of blood lead
levels in NHANES surveys has also identi-
fied special populations at high risk for
excessive lead exposure (e.g., black inner-
city children), which has helped target lead
poisoning prevention efforts.
Dioxin
The human toxicity of dioxin (used here to
refer to 2,3,7,8-tetrachlorodibenzo-p-
dioxin) has been a controversial and highly
publicized topic. Although considerable
data have amassed on the animal toxicity of
dioxin, concern over interspecies differ-
ences, high-dose to low-dose extrapolations
,and animal to human extrapolations have
highlighted the need for human studies to
help reduce uncertainties in dioxin risk
assessment. Biological monitoring of serum
and adipose tissue dioxin levels have made
a major contribution to human studies of
dioxin exposure. Figure 1 shows a compila-
tion of median serum dioxin levels of
selected populations across the world.
Except for the study of German plant
workers, these serum dioxin measurements
were made at CDC.
As with lead and other priority toxi-
cants, evaluation of the human exposure-
health effect relationship is based on the
results of multiple studies from occupa-
tional and environmental exposures.
Scientists need to know the relative
amounts of exposure in each study to be
able to combine results from multiple
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studies and validly interpret study results.
As shown in Figure 1, some populations
have median serum dioxin levels (expressed
on a lipid adjusted basis) as low as 3 to 4
parts per trillion (ppt) and some have
medians greater than 16,000 ppt. The
highest individual dioxin level ever mea-
sured was 56,000 ppt in a child in Seveso,
Italy (5). Individual serum dioxin levels
span more than four orders of magnitude.
The general premise of toxicology is
that higher exposure increases the likeli-
hood of observing an adverse effect. The
relationship between exposure (i.e., dose)
and effect (i.e., response) is often modeled
as a sigmoidal curve, but the shape of the
exposure-effect curve may take other
forms. By using biological monitoring to
identify populations with higher exposures,
relatively expensive epidemiologic.studies
can be efficiently targeted at people who
are most likely to demonstrate an adverse
health effect. In addition, if a health study
finds an adverse effect in a population of
"medium" exposure, scientists would
expect to be able to confirm that finding in
populations with higher exposure. Finally,
if scientists find a health effect to be small
among persons with low exposures, higher
(i.e., more prevalent or of greater magni-
tude) among persons with medium expo-
sure, and higher still among persons with
high exposure, then they have considerable
confidence that the exposure-health effect
relationship is causal.
The serum dioxin exposure informa-
tion in Figure 1 indicates the relative expo-
sure of different populations and thereby
permits scientists to better evaluate the
exposure-health effect relationship in
people. The highest dioxin levels ever
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Figure 1. Median serum dioxin levels in selected populations.
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measured have been found in persons in
Seveso, Italy, who were sampled within a
few months after an industrial explosion in
1976. Thus this population merits close
follow-up for adverse health effects.
Figure 1 also shows results of the
National Institute of Occupational Safety
and Health (NIOSH) occupational study
(6). Workers in this cohort had last been
exposed to dioxin in an occupational setting
15 to 37 years prior to the study. The work-
ers have been divided into exposure quin-
tiles with exposure defined by years of work
in jobs that had potential for dioxin expo-
sure. Figure 1 shows a steady increase in
median dioxin levels progressing from years-
of-work quintile 1 through 5, indicating
that serum dioxin levels correlate well with
years of work exposure. Serum dioxin levels
also showed how dioxin exposure in this
occupational cohort relates to dioxin expo-
sure of other populations. This cohort of
workers had relatively high dioxin levels and
is an excellent group for health studies,
which are under way.
The NIOSH occupational study also
illustrates a valuable use of biological moni-
toring when it is not possible to analyze a
biological specimen from all persons in the
study. This situation may occur, for exam-
ple, because the number of persons in the
study is too large or because some of the
persons are deceased. In the NIOSH study,
health outcomes (including cancer) were to
be evaluated on more than 5000 workers. A
sample of 253 workers was selected for
serum dioxin measurements. Using this
sample, the investigators compared differ-
ent methods of classifying exposure to
serum dioxin levels and determined that the
best exposure history/questionnaire infor-
mation for assessing exposure was years of
work in a job with potential exposure.
Furthermore, the investigators were able to
say how much dioxin exposure, on the
average, resulted from different numbers of
work-years in jobs with potential exposure.
By obtaining serum dioxin levels on a sub-
set of the study population, these scientists
were able to validate the exposure index
against the serum dioxin method. In addi-
tion, the exposure index was calibrated
against the serum dioxin levels, so exposure
in these workers could be compared to
exposure of other populations.
Serum dioxin levels have also been
measured in veterans of Operation Ranch
Hand, the Air Force personnel responsible
for aerial spraying of Agent Orange in
Vietnam. These serum dioxin measure-
ments were made approximately 20 years
after exposure in Vietnam ceased. To
interpret these dioxin levels, scientists need
to know the pharmacokinetics of dioxin in
people, especially how long dioxin persists
in the body. Studies of the pharmacokinet-
ics of dioxin in Ranch Hand veterans and
others (7,8) indicate that dioxin elimina-
tion follows first-order kinetics with a
half-life of 7 to 10 years. This half-life is
much longer than the half-life of a few
weeks to a few months observed in many
species of animals. Using this half-life esti-
mate, scientists can estimate the dioxin
level of veterans when they were exposed in
Vietnam. The Ranch Hand levels are
above background levels but not as
high as occupational levels found in the
NIOSH study.
Air Force scientists ranked expected
dioxin exposure of personnel in Operation
Ranch Hand based on job duties. The
ranking from high opportunity for expo-
sure to low opportunity for exposure was as
follows: enlisted men-nonflying > enlisted
men-flying > officers-flying > officers-non-
flying > controls. In Figure 1, the median
serum dioxin level is plotted for each of
these groups and the median follows the
order expected based on job duties. The Air
Force has obtained serum dioxin levels on
almost every participant of the Air Force
Health Study of Ranch Hand Veterans and
is using these levels to provide individual
estimates of dioxin exposure for each
veteran. This health study is to be contin-
ued through 2002, with detailed medi-
cal examinations of the veterans every
five years.
The top of the figure shows the results of
the CDC Agent Orange Validation Study
(AOVS) in which we measured serum
dioxin levels of ground troop Vietnam vet-
erans (excluding the Chemical Corps) in an
attempt to validate an exposure index to
assess exposure to Agent Orange and dioxin
among ground troop Vietnam veterans (9).
Veterans were dassified into low-, medium-,
and high-exposure groups based on the like-
lihood of exposure to Agent Orange. Five
exposure indices, based on military records,
were evaluated in an aggressive search for a
valid method of assessing exposure among
these veterans. An excess of ground troop
veterans with a high likelihood of exposure
(e.g., those who were in heavily sprayed
areas during heavy spraying) were intention-
ally included to bias the sample towards
higher exposed veterans.
Figure 1 shows the median dioxin levels
for the control, low-, medium-, and high-
exposed groups as classified by one of the
exposure indices. The other four exposure
indices showed similar results. Serum
dioxin levels for the persons classified as
high-exposed by exposure indices did not
statistically differ from the low-exposed
group or background exposure levels of
control veterans.
The AOVS had a 95% statistical power
to detect a difference of only 0.6 ppt in the
group serum dioxin medians between high-
and low-exposure groups (9). For example,
a change in median serum dioxin levels
going from the low-exposure group to the
high exposure group of 3.9 to 4.5 ppt. No
such difference was found. The serum levels
were measured about 19 to 20 years after
the veterans left Vietnam. Using a half-life
of 8 years, this 19 to 20 years would trans-
late to about 2.5 half-lifes. Thus, in the
AOVS study, the best estimate of the
median dioxin level of the high-exposed
group of ground troops during service in
Vietnam would be less than 7 to 8 ppt.
Seven to eight ppt is well within the
range of dioxin levels found in the control
group of veterans who never went to
Vietnam and within the range of dioxin
levels found in the U.S. population from
background exposures to dioxin (9). As
mentioned, ground troops were intention-
ally sampled to include veterans with high
potential for Agent Orange exposure, and
within that sample, the study examined
"high" exposure groups as defined by any of
five exposure indices; nonetheless, the
AOVS study was not able to find a group of
ground troop veterans whose median serum
dioxin level was above background levels.
Volatile Organic Compounds
Volatile organic compounds (VOCs)
include a number of animal carcinogens and
known or suspected human carcinogens.
CDC developed an isotope-dilution gas
chromatography mass-spectrometry method
to simultaneously measure 32 VOCs in 10
ml of blood with detection limits in the low
parts-per-trillion range (10). These com-
pounds include benzene, toluene, xylene,
ethylbenzene, styrene, chloroform, methyl-
ene chloride, tetrachlorethylene, and others.
Assessment of exposure to VOCs has been
of special concern in buildings and homes
with potential for poor indoor air quality.
Since many of the VOCs measured did
not have adequate "reference ranges" (i.e.,
normal or background ranges) or any refer-
ence range at all, CDC undertook a study of
1000 persons selected as a subset of the
NHANES III population to measure refer-
ence ranges for these VOCs. The study was
called the Priority Toxicant Reference Range
Study (PTRRS) and was partially funded by
the Agency for Toxic Substances and Disease
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Registry (ATSDR). The design of the study
included adequate sampling by age, gender,
race/ethnicity, urban/rural status, and region
of the country. The reference levels obtained
are reported elsewhere (11).
The PTRRS provided reference ranges
to aid in interpreting levels of VOCs in
other populations. During the PTRRS, the
Army requested CDC's assistance to help
assess the VOC exposure of Army troops
participating in Operation Desert Storm.
Since most of an inhaled VOC leaves the
body within a few days of exposure, it was
not appropriate to take blood samples from
veterans when they returned to the United
States. The Army and CDC designed a
sampling strategy that included three
phases: obtaining an initial blood sample in
Germany before going to Kuwait, obtain-
ing a second blood sample after two
months in Kuwait during the time the oil
fires were burning, and obtaining a third
blood sample when the soldiers returned to
Germany.
The results of the analysis for VOCs
showed no elevated VOC levels resulting
from exposure to the oil fires in Kuwait.
Furthermore, the range of levels of VOCs
for these Army troops could be compared
directly with reference ranges established in
the United States in the PTRRS. Levels of
VOCs were within the reference ranges
established in persons in the U.S. Careful
study design and biological monitoring for
VOCs provided important evidence that,
during the study period, these troops were
not excessively exposed to these VOCs as a
result of duty in Kuwait.
By contrast, in a companion study of
oil firefighters who worked in Kuwait,
CDC measured VOC levels in blood sam-
ples obtained on-site while the fires were
being fought (RA Etzel, DA Ashley,
unpublished data). The blood levels indi-
cated elevated (higher than background)
levels of benzene, ethylbenzene, mip-
xylene, o-xylene, styrene, and toluene in
some firefighters. The background range
established in the PTRRS allowed scientists
to recognize certain of the VOC levels as
above background.
Summary
Scientifically valid exposure assessment is
crucial to risk assessment, risk manage-
ment, and prevention of environmental
disease. Biological monitoring is a capable
exposure assessment tool that has provided
important information used in public
health decisions. Biological monitoring,
environmental monitoring, and exposure
history/questionnaire data should all be
considered as exposure assessment tools.
The specific needs and objectives in assess-
ing exposure in different situations should
determine which tool or tools are used.
Often, biological monitoring data and
environmental monitoring data are com-
plementary. In the future, more and better
pharmacokinetic and reference range data
for toxicant measurements in blood,
serum, and urine should significantly help
in our interpretation of biological moni-
toring measurements.
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